Williams Trevor, Duraid Hadi, Watson Sydeaka, Durkin Amy, Todd Kristy, Kindler Hedy L, Vigneswaran Wickii T
Department of Surgery, Section of Cardiac and Thoracic Surgery, University of Chicago Medicine, Chicago, Illinois.
Department of Biostatistics, Section of Hematology and Oncology, University of Chicago Medicine, Chicago, Illinois.
Ann Thorac Surg. 2015 Nov;100(5):1868-74. doi: 10.1016/j.athoracsur.2015.04.151. Epub 2015 Aug 25.
A survival advantage has been observed among patients with malignant pleural mesothelioma undergoing maximal cytoreductive surgery and adjuvant therapy. Elderly patients are considered higher risk for these radical operations and are commonly not offered surgical treatment. We reviewed our experience with extended pleurectomy and decortication among patients 70 years or older and compared them with a cohort of younger patients undergoing extended pleurectomy and decortication for malignant pleural mesothelioma.
We performed a retrospective review of 117 consecutive patients undergoing extended pleurectomy and decortication at a university hospital from January 2008 to December 2013. Patients 70 years and older were compared with younger patients for postoperative outcome and survival. Survival was estimated using the Kaplan-Meier method.
Fifty-four patients were 70 years or older; 63 were younger than 70 years. Older patients had more hypertension (71.2% versus 45.2%; p = 0.004) and coronary artery disease (22.6% versus 6.5%; p = 0.006). Major complications occurred in 3 patients (5.5%) in the older group and in 7 patients (11.1%) of the younger group (not significant). There were 2 deaths in each group after surgery (3.7% older versus 3.2% younger; not significant). Median survival was 15.6 months in the older patients and 14.0 months in the younger patients (not significant). Kaplan-Meier survival curves based on age groups were not significantly different with 1- and 2-year survivals of 64% versus 55% and 29% versus 32%, respectively.
Our study demonstrates that whereas age may be associated with more comorbid conditions in patients with malignant pleural mesothelioma undergoing extended pleurectomy and decortication, this does not necessarily translate into increased operative morbidity or mortality or shorter long-term survival.
在接受最大程度细胞减灭术和辅助治疗的恶性胸膜间皮瘤患者中观察到了生存优势。老年患者被认为进行这些根治性手术的风险更高,通常不提供手术治疗。我们回顾了70岁及以上患者行扩大胸膜切除术和剥脱术的经验,并将其与一组接受扩大胸膜切除术和剥脱术治疗恶性胸膜间皮瘤的年轻患者进行比较。
我们对2008年1月至2013年12月在一家大学医院连续接受扩大胸膜切除术和剥脱术的117例患者进行了回顾性研究。将70岁及以上的患者与年轻患者的术后结局和生存率进行比较。采用Kaplan-Meier法估计生存率。
54例患者年龄在70岁及以上;63例患者年龄小于70岁。老年患者高血压(71.2%对45.2%;p = 0.004)和冠状动脉疾病(22.6%对6.5%;p = 0.006)更多。老年组3例患者(5.5%)发生主要并发症,年轻组7例患者(11.1%)发生主要并发症(无统计学意义)。每组术后均有2例死亡(老年组3.7%,年轻组3.2%;无统计学意义)。老年患者的中位生存期为15.6个月,年轻患者为14.0个月(无统计学意义)。基于年龄组的Kaplan-Meier生存曲线无显著差异,1年和2年生存率分别为64%对55%和29%对32%。
我们的研究表明,虽然年龄可能与接受扩大胸膜切除术和剥脱术的恶性胸膜间皮瘤患者更多的合并症相关,但这不一定会转化为手术发病率或死亡率增加或长期生存期缩短。